Our Products

Avadel has a diverse portfolio of FDA-approved and marketed products across the primary care and hospital spaces. We pride ourselves not only on our drug delivery capabilities but on our efforts to commercialize safe and effective products. Avadel was the first to receive FDA approval for a number of commonly used anesthesia products: Neostigmine Methylsulfate Injection, USP (Bloxiverz®), Phenylephrine HCI Injection (Vazculep®), and Ephedrine Sulfate Injection, USP (Akovaz®).